Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
388,311,585
-
Total 13F shares
-
102,851,929
-
Share change
-
+1,004,090
-
Total reported value
-
$3,035,078,555
-
Put/Call ratio
-
153%
-
Price per share
-
$29.49
-
Number of holders
-
333
-
Value change
-
+$32,884,432
-
Number of buys
-
104
-
Number of sells
-
145
Institutional Holders of Moderna, Inc. - Common Stock (MRNA) as of Q4 2025
As of 31 Dec 2025,
Moderna, Inc. - Common Stock (MRNA) was held by
333 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
102,851,929 shares.
The largest 10 holders included
VANGUARD GROUP INC, BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, BNP PARIBAS FINANCIAL MARKETS, UBS Group AG, GOLDMAN SACHS GROUP INC, BANQUE PICTET & CIE SA, NORGES BANK, Bank of New York Mellon Corp, and Douglas Lane & Associates, LLC.
This page lists
333
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.